Overexpression of OCT4 has been observed in multiple cancers, including lung, prostate, liver, and cervical cancers, as well as ovarian cancer (Liu et al., 2011; Iki and Pour, 2006; Wang et al., 2010). This evidence concerns the gene POU5F1 and cancer.